Intermediate for Idelalisib. Idelalisib (trade name Zydelig) is a phosphoinositide 3-kinase inhibitor for the treatment of certain hematological malignancies. Idelalisib has been approved by the U.S Food and Drug Administration on July 23, 2014.
Product Name: (S)-2-(1-Aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one
CAS Number: 870281-86-0
Molecular Weight:  297.3313
Molecular Formula:  C17H16FN3O
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.